Literature DB >> 6336155

Antineoplastic effect of the xanthine derivative Trental.

W Biddle, C M Ambrus, H Gastpar, J L Ambrus.   

Abstract

The xanthine derivative, Trental (pentoxifylline) was found to inhibit several human leukemic and lymphoma cell lines in tissue cultures. Optimal concentrations were less inhibitory for a normal B-lymphocyte cell line then for the neoplastic cell lines. In fact, small concentrations stimulated DNA synthesis in the normal cell line. Trental and beta-interferon appeared to be additive synergists at certain dosages. Possible mechanisms are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6336155

Source DB:  PubMed          Journal:  J Med        ISSN: 0025-7850


  3 in total

1.  Potentiation of cisplatin cytotoxicity by methylxanthines in vitro.

Authors:  E Petru; G Boike; B U Sevin
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  Discovering discovery patterns with Predication-based Semantic Indexing.

Authors:  Trevor Cohen; Dominic Widdows; Roger W Schvaneveldt; Peter Davies; Thomas C Rindflesch
Journal:  J Biomed Inform       Date:  2012-07-26       Impact factor: 6.317

Review 3.  Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy.

Authors:  A Ward; S P Clissold
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.